0001387131-14-003415.txt : 20141010 0001387131-14-003415.hdr.sgml : 20141010 20141010163541 ACCESSION NUMBER: 0001387131-14-003415 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20141010 DATE AS OF CHANGE: 20141010 EFFECTIVENESS DATE: 20141010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mati Therapeutics Inc. CENTRAL INDEX KEY: 0001574251 IRS NUMBER: 462000931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-226250 FILM NUMBER: 141152749 BUSINESS ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 329-6360 MAIL ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0707 D LIVE 0001574251 Mati Therapeutics Inc. 4317 DUNNING LANE AUSTIN TX TEXAS 78746 (512) 329-6360 DELAWARE 10152012, Inc. None Corporation true 2012 Robert Lee Butchofsky II 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Director Chris Muller 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Director Deepank Utkede 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Director Cameron Nelson 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Biotechnology Decline to Disclose 06c false 2014-09-30 true true false 0 Carrollton Capital Partners, LLC 165470 None None 12 FIVE MILE RIVER ROAD DARIEN CT CONNECTICUT 06820 All States false 13800000 150000 13650000 false 2 690000 true 0 This estimate is based on sales commissions of 5% of the full offering amount, up to $690,000, and assumes the total offering is sold and that a commission is payable in respect of all subscriptions. 1300000 true This estimate includes projected salaries and compensation to officers, reimbursement of expenses incurred, and the repayment of short term debt loaned to the Issuer by certain officers and directors. false Mati Therapeutics Inc. /s/ Robert Lee Butchofsky II Robert Lee Butchofsky II President & Secretary 2014-10-07